Sign Up to like & get
recommendations!
1
Published in 2019 at "Medical Decision Making"
DOI: 10.1177/0272989x19832879
Abstract: Background. Gain in mean survival time from new cancer treatments is a core component of cost-effectiveness analyses frequently used by payers for reimbursement decisions. Due to limited follow-up time, clinical trials rarely report this measure,…
read more here.
Keywords:
mean survival;
differences mean;
cancer;
survival time ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Statistical Methods in Medical Research"
DOI: 10.1177/09622802221146310
Abstract: Covariate balance is crucial in obtaining unbiased estimates of treatment effects in observational studies. Methods that target covariate balance have been successfully proposed and largely applied to estimate treatment effects on continuous outcomes. However, in…
read more here.
Keywords:
weights optimally;
hazard;
marginal hazard;
hazard ratios ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Clinical Epidemiology"
DOI: 10.2147/clep.s225763
Abstract: Abstract Associations between an exposure and multiple competing events are typically described by cause-specific hazard ratios (csHR) or subdistribution hazard ratios (sHR). However, diagnostic tools to assess differences between them have not been described. Under…
read more here.
Keywords:
shr cshr;
racial differences;
cshr;
hazard ratios ... See more keywords